Office of Surveillance and Epidemiology Annual Report 2020 - FDA/CDER/OSE

CDER's Office of Surveillance and Epidemiology (OSE) recently issued their first Annual Report. The 2020 Annual Report highlights OSE’s key initiatives to improve public health by reviewing and assessing the safety of medicines, with a special focus on its efforts to respond to the COVID-19 pandemic. The report also provides insight into OSE's key initiatives to detect, assess, prevent, and monitor the risks of medicines.

View Report